Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding stock today
Tonix Pharmaceuticals Holding closed at $5.10 on October 30, 2026, down 3.41% on the day. Over the past year it returned -71.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $81.0 million.
| Period | TNXP | S&P 500 (SPY) |
|---|---|---|
| 1 month | -47.6% | -0.9% |
| 3 months | -49.5% | +2.1% |
| Year to date | -67.3% | +11.7% |
| 1 year | -71.8% | +12.4% |
| 3 years | -99.7% | +88.5% |
| 5 years | -100.0% | +76.0% |
Key statistics
- Market value
- $81.0M
- Price / sales
- 2.8
- 52-week range
- $5.10 to $19.89
- Next report
- Nov 9, 2026
About Tonix Pharmaceuticals Holding
Develops pharmaceutical treatments for neuropsychiatric and infectious diseases.
Sector: Health Care
More on Tonix Pharmaceuticals Holding
- Financials: revenue, earnings and segmentsRevenue +30% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $0.00 today
No forecast, no recommendation. This page describes Tonix Pharmaceuticals Holding Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.